Announcement under Regulation 30 (LODR)-Investor Presentation
Filed with BSE · · 29 pages · English
Summary by 6ix AI
Sudarshan Pharma Industries Ltd has submitted an investor presentation regarding the proposed acquisition of a manufacturing plant, as required by regulatory obligations. The presentation outlines the facility's location, operational capabilities, and compliance with international quality standards. The document serves to inform stakeholders about the strategic move to enhance production capacity and capabilities.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Sudarshan Pharma Industries Ltd on 6ix
Earlier from Sudarshan Pharma Industries
- Sudarshan Pharma Industries Ltd Press Release Aug 10 2026
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
- Sudarshan Pharma Industries Ltd Press Release Aug 09 2026
- Board Meeting Intimation for To Consider And Approve Financial Results For The Quarter Ended 30/June/2026
- Sudarshan Pharma Industries Ltd Press Release Jul 14 2026
Later from Sudarshan Pharma Industries
- FCCB Committee Meeting On Wednesday, 19-August-2026
- Sudarshan Pharma Industries Ltd Press Release Aug 14 2026
- Sudarshan Pharma Industries Ltd Press Release Aug 17 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Sudarshan Pharma Industries Ltd Press Release Aug 18 2026
Follow Sudarshan Pharma Industries into a list and get an email when it puts out news.
Follow Sudarshan Pharma Industries